BICO News Feed

Discover the latest news from our business areas.

September 23, 2024 | Cytena

Unlocking the Future of Medicine: The Promise and Techniques of Allogeneic Stem Cell Therapies

September 16, 2024 | Cytena

Automation in iPSC-based Cell Therapy Generation: Increasing Efficiency and Consistency

September 9, 2024 | Cytena

Allogeneic iPS Cell‐based Therapy: Key Techniques and Methods

September 3, 2024 | Bico

MatTek Life Sciences Licenses Cutting-Edge In Vitro Human Tissue Technology to Leading Production Laboratory in China

September 2, 2024 | Cytena

Therapeutic Potential of iPSC-derived Allogeneic Cell Therapies: A Game Changer in Regenerative Medicine

August 27, 2024 | Cytena

Streamlining Monoclonal Antibody Production: From Quality Control to Cost Management

August 19, 2024 | Cytena

Optimizing Your Monoclonal Antibody Production Workflow

August 12, 2024 | Cytena

Therapeutic Monoclonal Antibody Applications

August 6, 2024 | Cytena

Hybridoma Technology: Quality Control and Best Practices